Stefan M Pfister
Overview
Explore the profile of Stefan M Pfister including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
491
Citations
44070
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hirsch S, Rahmanzade R, Grund K, Sutter C, Schramm K, Selt F, et al.
Acta Neuropathol
. 2025 Mar;
149(1):25.
PMID: 40085243
No abstract available.
2.
Achatz M, Villani A, Bertuch A, Bougeard G, Chang V, Doria A, et al.
Clin Cancer Res
. 2025 Mar;
PMID: 40072304
Li-Fraumeni syndrome (LFS) is an autosomal dominant cancer predisposition condition characterized by a high lifetime risk for a wide spectrum of malignancies associated with germline pathogenic/likely pathogenic (P/LP) variants in...
3.
Mateos M, Ajuyah P, Fuentes-Bolanos N, El-Kamand S, Barahona P, Altekoester A, et al.
Neuro Oncol
. 2025 Mar;
PMID: 40072012
Background: Factors that drive the development of diffuse midline gliomas (DMG) are unknown. Our study aimed to determine the prevalence of pathogenic/likely pathogenic (P/LP) germline variants in pediatric patients with...
4.
Delaidelli A, Burwag F, Ben-Neriah S, Suk Y, Shyp T, Kosteniuk S, et al.
Neuro Oncol
. 2025 Mar;
PMID: 40040502
Background: While international consensus and the 2021 WHO classification recognize multiple molecular medulloblastoma subgroups, these are difficult to identify in clinical practice utilizing routine approaches. As a result, biology-driven risk...
5.
Benfatto S, Sill M, Jones D, Pfister S, Sahm F, von Deimling A, et al.
Nat Commun
. 2025 Feb;
16(1):1787.
PMID: 39979307
We have recently developed a machine learning classifier that enables fast, accurate, and affordable classification of brain tumors based on genome-wide DNA methylation profiles that is widely employed in the...
6.
Stock A, Krumma J, Fleischhack G, Tippelt S, Rink L, Pietsch T, et al.
Neuroradiology
. 2025 Feb;
PMID: 39960531
Purpose: Currently, the different types of ependymal neoplasm (EPN) are defined by anatomical localization and genetics. This retrospective multicenter study aimed to analyze the imaging patterns of both local and...
7.
Perrino M, Jongmans M, Tomlinson G, Greer M, Scollon S, Mitchell S, et al.
Clin Cancer Res
. 2025 Feb;
PMID: 39937237
Schwannomatoses (SWN) are distinct cancer predisposition syndromes caused by germline pathogenic variants in the genes NF2, SMARCB1, or LZTR1. There is significant clinical overlap between these syndromes with the hallmark...
8.
Aldape K, Capper D, von Deimling A, Giannini C, Gilbert M, Hawkins C, et al.
Neurooncol Adv
. 2025 Feb;
7(1):vdae228.
PMID: 39902391
Genome-wide DNA methylation signatures correlate with and distinguish central nervous system (CNS) tumor types. Since the publication of the initial CNS tumor DNA methylation classifier in 2018, this platform has...
9.
Hinz F, Friedel D, Korshunov A, Ippen F, Bogumil H, Banan R, et al.
Acta Neuropathol
. 2025 Feb;
149(1):12.
PMID: 39899075
IDH-mutant astrocytomas are diffuse gliomas that are defined by characteristic mutations in IDH1 or IDH2 and do not have complete 1p/19q co-deletion. The established grading criteria include histological features of...
10.
Pfaff E, Schramm K, Blattner-Johnson M, Jones B, Stark S, Balasubramanian G, et al.
Neurooncol Adv
. 2025 Feb;
7(1):vdae185.
PMID: 39896072
Background: High-grade glioma (HGG) of the spinal cord constitutes rare tumors in the pediatric population. Knowledge of the molecular profile of this pediatric HGG (pedHGG) subgroup is limited and the...